*Understanding the SGLT2 Receptor and its Related Genetics (SLC5A2 Gene): Identifying a Unique Phenotype and Necessary Therapeutic Intervention — A Hypothesis*

Documenti analoghi

• Repaglinide Revisited: A Temporal Insulin Alignment Hypothesis for β-Cell Preservation and Metabolic Efficiency in Type 2 Diabetes Mellitus
  di: Mishra, Aditya
  Pubblicazione: (2026)
• A Multi‐Phenotype Approach to Joint Testing of Main Genetic and Gene‐Environment Interaction Effects
  di: Saurabh Mishra, et al.
  Pubblicazione: (2025)
• SGLT‐2 Inhibitors Are Potent to Suppress Aggressive Transformation From Indolent Type of Adult T‐Cell Leukemia/Lymphoma: Unique Insight Into Therapeutics for Diabetes‐Related Hematological Malignancy
  di: Kazuho Morichika, et al.
  Pubblicazione: (2025)
• Disruption of the l ‐ DOPA Receptor Gpr143/OA1 ‐Gene in Mice Creates a Unique Mixed Psychosis‐Like Phenotype
  di: Yoshio Goshima, et al.
  Pubblicazione: (2026)
• Estrogen‐Related Receptor Gamma (ERRγ) as Biomarker and Novel Target for Therapeutic Intervention on Cancer: A Review
  di: Priyanka Upadhyay, et al.
  Pubblicazione: (2024)